Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
It's not good I'll tell you that. No one in that gang brings any value
They're going to move the property to joshua gold. Currah has been vocal over there
Analysis video
I believe the only requirement holding us back at this point is shareholder equity. That can be resolved with a raise, or revenue, and I believe the company is waiting on the results so they can satisfy that requirement with revenue.
Well Gilead just had a $5b deal crap out...so who knows.
Care to elaborate?
Everyone else is fine with the transaction that has taken place, there was no huge drop, and the hit article was corrected. At this point it is old news, and time to move on.
So if she's not an affiliate, and just a common shareholder then why the SEC form? Are we going to see one of these from every shareholder that exercises warrants.
NO!
She did not sell hence the correction piece from AF and Stat news.
Perhaps you should reach out to the company for clarification, please feel free to post their response.
Based on what?
You can't have some vote and some not vote. If Currah and co are the ones calling said meeting what they get to vote themselves back in?
I called Ameritrade and they did not seem to know anything about this meeting? Usually I get an email with a link to proxy.
Can you please elaborate on this?
I believe this is Philippines based which would put it 7pm their time. Could be wrong but it specifically mentions Philippines.
There was a proactive video a week ago providing updates
I noticed that as well. Odd.
I like your thinking
Showing up $.40 pre market
There are quite a few people who poured into CYDY reddit over the weekend. With platforms halting people from buying, they may turn to the OTC where there are less rules. Either way it's good to get the word out.
What happened to 1/21? It came and passed, no events happened.
Again, I see you've posted several times, why do we have to wait until tomorrow? What is the catalyst?
Why do we have to wait until Monday? Will the company release news on Monday, or is that when you plan to unveil your FUD when the market is open?
Several hopefuls before admission
Such so-called dampening immunomodulators, which slow down an excessive immune reaction, could increasingly come onto the market in the near future. Vfa spokesman Hömke refers to several agents that are in phase III and which, if the positive interim results are confirmed, could be submitted for approval in the next few months. These include the MK-7110 from MSD, Leronlimab from CytoDyn and Siltuximab from Eusa Pharma. German companies are also in the running here. The Jena-based company InflaRx is testing in a phase II / III study whether the agent vilobelimab can help Covid-19 seriously ill people. And the German-American Immunic Therapeutics is testing its IMU-838 immunomodulator in two Phase II studies with inpatient corona patients.
https://www.tagesschau.de/wirtschaft/corona-medikament-101.html
As far as I know they're so still there
So Currah has been back and forth on joshua gold resources. My belief is that are the ones that are trying to kick Dan and co out to acquire the property for pay "debt". And transfer to joshua gold and start a new pump.
What's the news
What's it say
If you are concerned I suggest you reach out to Cytodyns corporate lawyer, Arian. acolachis@cytodyn.com
Please feel free to post her response.
That was from November 20
You know the data for HIV, it's 81% efficient with 350mg combo. The hard part is done, just a matter of submitting to the government in the correct format. So YES it does work and we should get revenue for something.
Per the call they stated 10-14 days for EUA submission to the Philippines. IMO would allow for the top line data to be introduced from CD12, and 14 days from the call puts them on the 21st. So relax, Covid isn't going anywhere.
Aside from the revenue, Cytodyn has an opportunity to save lives but chooses not to?
Why not just have the call in a week and take about the top line data?
Thinking the same thing .. And we may have not had to do any raises???
US just hit a new record yesterday for Covid deaths 3700+
https://www.cnn.com/2020/12/30/health/us-coronavirus-wednesday/index.html
It is a bit concerning that they applied in September and just got rejected at the end of December.
The competition with therapeutics is running out, and as I recall all of the BP's got theirs approved. So I would hope that they approve something that actually works for once.
U.S. Food and Drug Administration rejected its bid for emergency approval of the drug aviptdadil in critically ill COVID-19 patients.
https://www.devdiscourse.com/article/health/1388159-relief-therapeutics-stock-plunges-after-fda-rejects-covid-19-emergency-approval
I really have no idea why they do these calls to "update us on timelines" Just get it done then have a call. Right now they just told the shorts that nothing is coming for at least a week. Between this and MM selling any momo is gone.
Right now there is only 2 things that need to happen, get the CD12 data ready to submit and finish the BLA to submit. We don't need updates of when, just get it done.